help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 4, 2007
Molecular Endocrinology, doi:10.1210/me.2007-0241
Molecular Endocrinology Vol. 0, No. 2007 200702411-
doi:10.1210/me.2007-0241
Copyright © 2007 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
22/1/196    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilkenny, D. M.
Right arrow Articles by Rocheleau, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilkenny, D. M.
Right arrow Articles by Rocheleau, J. V.

Submitted on May 9, 2007
Accepted on September 24, 2007

Fibroblast Growth Factor Receptor-1 Signaling in Pancreatic Islet {beta}-cells is Modulated by the Extracellular Matrix

Dawn M. Kilkenny and Jonathan V. Rocheleau*

Cell Imaging Shared Resource, Vanderbilt University Medical Center, 37232-0615; Molecular Physiology and Biophysics, Vanderbilt University Medical Center, 37232-0615

* To whom correspondence should be addressed. E-mail: Jon.Rocheleau{at}vanderbilt.edu.

Maintenance of pancreatic {beta}-cell mass depends on extracellular stimuli that promote survival and proliferation. In the islet, these stimuli come from the {beta}-cell microenvironment and include extracellular matrix (ECM) deposited by associated vascular endothelial cells. Fibroblast growth factor receptor-1 (FGFR1) has recently been implicated as a signaling pathway that is important for normal {beta}-cell function. We would like to understand how ECM- and FGFR1-signaling interact to promote {beta}-cell survival and proliferation. To examine {beta}-cell-specific receptor responses, we created lentiviral vectors with rat insulin promoter-driven expression of Venus fluorescent protein-tagged full-length (R1{beta}v) and kinase-deficient (KDR1{beta}v) FGFR1. Significant FGF-1-dependent activation of ERK1/2 was observed in {beta}TC3 cells, dispersed {beta}-cells and {beta}-cells in intact islets. This response was enhanced by R1{beta}v expression and reduced by KDR1{beta}v expression. Plating dispersed {beta}-cells on collagen type IV resulted in enhanced expression of endogenous FGFR1 that was associated with sustained activation of ERK1/2. Conversely, plating cells on laminin reduced expression of FGFR1 and this reduction was associated with transient activation of ERK1/2. Addition of neutralizing antibodies to inhibit {beta}-cell attachment to laminin via {alpha}6-integrin increased high-affinity FGF-1-binding at the plasma membrane and resulted in sustained ERK1/2 activity similar to cells plated on collagen type IV. These data show that the FGF-stimulated {beta}-cell response is negatively affected by {alpha}6-integrin binding to laminin, and suggest regulation associated with vascular endothelial cell remodeling.


Key words: {beta}-cell • islet • extracellular matrix • FGFR1 • ERK1/2




This article has been cited by other articles:


Home page
DiabetesHome page
N. Grarup, G. Andersen, N. T. Krarup, A. Albrechtsen, O. Schmitz, T. Jorgensen, K. Borch-Johnsen, T. Hansen, and O. Pedersen
Association Testing of Novel Type 2 Diabetes Risk Alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 Loci With Insulin Release, Insulin Sensitivity, and Obesity in a Population-Based Sample of 4,516 Glucose-Tolerant Middle-Aged Danes
Diabetes, September 1, 2008; 57(9): 2534 - 2540.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society